Rubin M. Tuder

45.8k total citations · 16 hit papers
330 papers, 33.1k citations indexed

About

Rubin M. Tuder is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Rubin M. Tuder has authored 330 papers receiving a total of 33.1k indexed citations (citations by other indexed papers that have themselves been cited), including 239 papers in Pulmonary and Respiratory Medicine, 91 papers in Molecular Biology and 44 papers in Physiology. Recurrent topics in Rubin M. Tuder's work include Pulmonary Hypertension Research and Treatments (144 papers), Neonatal Respiratory Health Research (51 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers). Rubin M. Tuder is often cited by papers focused on Pulmonary Hypertension Research and Treatments (144 papers), Neonatal Respiratory Health Research (51 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (44 papers). Rubin M. Tuder collaborates with scholars based in United States, United Kingdom and Brazil. Rubin M. Tuder's co-authors include Norbert F. Voelkel, Carlyne D. Cool, Irina Petrache, N. F. Voelkel, Steven H. Abman, Paul M. Hassoun, Yasunori Kasahara, Lijie Zhen, Laimute Taraseviciene‐Stewart and Brian B. Graham and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Rubin M. Tuder

327 papers receiving 32.5k citations

Hit Papers

Inhibition of VEGF receptors causes lung cell apoptosis a... 1994 2026 2004 2015 2000 2004 2004 2012 1994 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
    2000 862 citations Yasunori Kasahara, Rubin M. Tuder et al. profile →
  2. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
    2004 740 citations Tirumalai Rangasamy, Thomas W. Kensler et al. profile →
  3. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke–induced emphysema in mice
    2004 696 citations Tirumalai Rangasamy, Thomas W. Kensler et al. profile →
  4. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis
    2012 648 citations Eric P. Schmidt, Yimu Yang et al. Nature Medicine profile →
  5. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.
    1994 633 citations Rubin M. Tuder, David B. Badesch et al. profile →
  6. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension
    2001 630 citations Yasunori Kasahara, Rubin M. Tuder et al. profile →
  7. Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension
    1999 605 citations Rubin M. Tuder, Carlyne D. Cool et al. American Journal of Respiratory and Critical Care Medicine profile →
  8. Endothelial Dysfunction in Pulmonary Hypertension
    2004 581 citations Rubin M. Tuder et al. Circulation profile →
  9. Short telomeres are a risk factor for idiopathic pulmonary fibrosis
    2008 553 citations Jonathan K. Alder, Julian J.‐L. Chen et al. Proceedings of the National Academy of Sciences profile →
  10. Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema
    2001 544 citations Yasunori Kasahara, Rubin M. Tuder et al. American Journal of Respiratory and Critical Care Medicine profile →
  11. Inhibition of angiogenesis decreases alveolarization in the developing rat lung
    2000 513 citations Rubin M. Tuder, Steven H. Abman et al. American Journal of Physiology-Lung Cellular and Molecular Physiology profile →
  12. Pathologic assessment of vasculopathies in pulmonary hypertension
    2004 511 citations Rubin M. Tuder et al. profile →
  13. Modern Age Pathology of Pulmonary Arterial Hypertension
    2012 466 citations Elvira Stacher, Brian B. Graham et al. American Journal of Respiratory and Critical Care Medicine profile →
  14. Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
    2013 419 citations Rubin M. Tuder, Serpil C. Erzurum et al. profile →
  15. Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
    2007 408 citations Toshinori Yoshida, Rubin M. Tuder profile →
  16. Expression of angiogenesis‐related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis
    2001 391 citations Rubin M. Tuder, Jun Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rubin M. Tuder United States 98 20.6k 9.7k 5.4k 5.0k 4.0k 330 33.1k
Friedrich Grimminger Germany 90 18.5k 0.9× 7.2k 0.7× 8.3k 1.5× 5.7k 1.2× 3.1k 0.8× 556 31.3k
Norbert F. Voelkel United States 84 16.8k 0.8× 6.1k 0.6× 8.1k 1.5× 3.0k 0.6× 3.9k 1.0× 274 24.8k
Marlene Rabinovitch Canada 80 14.6k 0.7× 7.4k 0.8× 6.6k 1.2× 2.2k 0.4× 4.4k 1.1× 316 25.0k
Kurt R. Stenmark United States 70 13.2k 0.6× 6.7k 0.7× 5.5k 1.0× 2.7k 0.5× 3.1k 0.8× 344 21.7k
Victor J. Thannickal United States 85 11.9k 0.6× 10.2k 1.1× 1.5k 0.3× 4.1k 0.8× 3.2k 0.8× 231 28.7k
Lilach O. Lerman United States 84 7.0k 0.3× 7.3k 0.8× 7.9k 1.5× 4.0k 0.8× 6.5k 1.6× 674 29.6k
Joe G. N. Garcia United States 92 7.3k 0.4× 15.3k 1.6× 2.2k 0.4× 5.1k 1.0× 2.0k 0.5× 577 30.8k
Hossein Ardeschir Ghofrani Germany 86 27.9k 1.4× 5.2k 0.5× 17.9k 3.3× 4.0k 0.8× 3.5k 0.9× 635 34.8k
Guy A. Zimmerman United States 98 4.6k 0.2× 10.5k 1.1× 2.9k 0.5× 3.0k 0.6× 3.9k 1.0× 262 32.6k
Jesús Egido Spain 91 3.4k 0.2× 10.6k 1.1× 5.6k 1.0× 2.9k 0.6× 5.1k 1.3× 621 31.6k

Countries citing papers authored by Rubin M. Tuder

Since Specialization
Citations

This map shows the geographic impact of Rubin M. Tuder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rubin M. Tuder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rubin M. Tuder more than expected).

Fields of papers citing papers by Rubin M. Tuder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rubin M. Tuder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rubin M. Tuder. The network helps show where Rubin M. Tuder may publish in the future.

Co-authorship network of co-authors of Rubin M. Tuder

This figure shows the co-authorship network connecting the top 25 collaborators of Rubin M. Tuder. A scholar is included among the top collaborators of Rubin M. Tuder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rubin M. Tuder. Rubin M. Tuder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vohwinkel, Christine U., Nana Burns, Xiaoyi Yuan, et al.. (2022). HIF1A-dependent induction of alveolar epithelial PFKFB3 dampens acute lung injury. JCI Insight. 7(24). 17 indexed citations
2.
Kumar, Rahul, Claudia Mickael, Biruk Kassa, et al.. (2019). Interstitial macrophage-derived thrombospondin-1 contributes to hypoxia-induced pulmonary hypertension. Cardiovascular Research. 116(12). 2021–2030. 53 indexed citations
3.
Haeger, Sarah M., Xinyue Liu, Xiaorui Han, et al.. (2018). Epithelial Heparan Sulfate Contributes to Alveolar Barrier Function and Is Shed during Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 59(3). 363–374. 42 indexed citations
4.
Graham, Brian B., Jacob J. Chabon, Rahul Kumar, et al.. (2013). Protective Role of IL-6 in Vascular Remodeling in Schistosoma Pulmonary Hypertension. American Journal of Respiratory Cell and Molecular Biology. 49(6). 951–959. 37 indexed citations
5.
Messier, Elise M., Brian J. Day, Steven R. Kleeberger, et al.. (2013). N -Acetylcysteine Protects Murine Alveolar Type II Cells from Cigarette Smoke Injury in a Nuclear Erythroid 2–Related Factor–2–Independent Manner. American Journal of Respiratory Cell and Molecular Biology. 48(5). 559–567. 38 indexed citations
6.
Goncharov, Dmitry A., Tatiana V. Kudryashova, Kaori Ihida‐Stansbury, et al.. (2013). Mammalian Target of Rapamycin Complex 2 (mTORC2) Coordinates Pulmonary Artery Smooth Muscle Cell Metabolism, Proliferation, and Survival in Pulmonary Arterial Hypertension. Circulation. 129(8). 864–874. 159 indexed citations
7.
Ghosh, Manik C., De‐Liang Zhang, Suh Young Jeong, et al.. (2013). Deletion of Iron Regulatory Protein 1 Causes Polycythemia and Pulmonary Hypertension in Mice through Translational Derepression of HIF2α. Cell Metabolism. 17(2). 271–281. 156 indexed citations
8.
Hunt, James M., Brian Bethea, Xiang Liu, et al.. (2013). Pulmonary veins in the normal lung and pulmonary hypertension due to left heart disease. American Journal of Physiology-Lung Cellular and Molecular Physiology. 305(10). L725–L736. 44 indexed citations
9.
Schmidt, Eric P., Yimu Yang, William J. Janssen, et al.. (2012). The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nature Medicine. 18(8). 1217–1223. 648 indexed citations breakdown →
10.
Tuder, Rubin M. & Toshinori Yoshida. (2011). Stress Responses Affecting Homeostasis of the Alveolar Capillary Unit. Proceedings of the American Thoracic Society. 8(6). 485–491. 7 indexed citations
11.
Alder, Jonathan K., Nini Guo, Erin M. Parry, et al.. (2011). Telomere Length Is a Determinant of Emphysema Susceptibility. American Journal of Respiratory and Critical Care Medicine. 184(8). 904–912. 178 indexed citations
12.
Alder, Jonathan K., Julian J.‐L. Chen, Lisa Lancaster, et al.. (2008). Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proceedings of the National Academy of Sciences. 105(35). 13051–13056. 553 indexed citations breakdown →
13.
Sussan, Thomas E., Tirumalai Rangasamy, David J. Blake, et al.. (2008). Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice. Proceedings of the National Academy of Sciences. 106(1). 250–255. 282 indexed citations
14.
Xu, Weiling, Thomas Koeck, Abigail Lara, et al.. (2007). Alterations of cellular bioenergetics in pulmonary artery endothelial cells. Proceedings of the National Academy of Sciences. 104(4). 1342–1347. 316 indexed citations
15.
Kasahara, Yasunori, Rubin M. Tuder, Carlyne D. Cool, et al.. (2001). Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema. American Journal of Respiratory and Critical Care Medicine. 163(3). 737–744. 544 indexed citations breakdown →
16.
Lee, Ji‐Hyun, In‐Chul Lee, Rubin M. Tuder, et al.. (2001). Pathogenic Role of Endothelin 1 in Hemodynamic Dysfunction in Experimental Acute Pulmonary Thromboembolism. American Journal of Respiratory and Critical Care Medicine. 164(7). 1282–1287. 40 indexed citations
17.
Tuder, Rubin M., Carlyne D. Cool, Jun Wang, et al.. (1999). Prostacyclin Synthase Expression Is Decreased in Lungs from Patients with Severe Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 159(6). 1925–1932. 605 indexed citations breakdown →
18.
Tuder, Rubin M., Zivotije Radisavljevic, Kenneth R. Shroyer, Julia M. Polak, & NORBERT F. VOELKEL. (1998). Monoclonal Endothelial Cells in Appetite Suppressant–associated Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 158(6). 1999–2001. 56 indexed citations
19.
Wright, Laurel, Rubin M. Tuder, Jun Wang, et al.. (1998). 5-Lipoxygenase and 5-Lipoxygenase Activating Protein (FLAP) Immunoreactivity in Lungs from Patients with Primary Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 157(1). 219–229. 109 indexed citations
20.
Nicolls, Mark R., Lance S. Terada, Rubin M. Tuder, Sheila A. Prindiville, & Marvin I. Schwarz. (1998). Diffuse Alveolar Hemorrhage with Underlying Pulmonary Capillaritis in the Retinoic Acid Syndrome. American Journal of Respiratory and Critical Care Medicine. 158(4). 1302–1305. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Friedrich Grimminger Breakdown of academic impact, for papers by Norbert F. Voelkel Breakdown of academic impact, for papers by Marlene Rabinovitch Breakdown of academic impact, for papers by Kurt R. Stenmark Breakdown of academic impact, for papers by Victor J. Thannickal Breakdown of academic impact, for papers by Lilach O. Lerman Breakdown of academic impact, for papers by Joe G. N. Garcia Breakdown of academic impact, for papers by Hossein Ardeschir Ghofrani Breakdown of academic impact, for papers by Guy A. Zimmerman Breakdown of academic impact, for papers by Jesús Egido
Rankless by CCL
2026